BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32849921)

  • 1. Elucidating the fate of nanoparticles among key cell components of the tumor microenvironment for promoting cancer nanotechnology.
    Bromma K; Bannister A; Kowalewski A; Cicon L; Chithrani DB
    Cancer Nanotechnol; 2020; 11(1):8. PubMed ID: 32849921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-Mediated Uptake and Retention of Gold Nanoparticles in Tumor Cells and in Cancer-Associated Fibroblasts.
    Alhussan A; Bromma K; Perez MM; Beckham W; Alexander AS; Howard PL; Chithrani DB
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticle mediated radiation response among key cell components of the tumour microenvironment for the advancement of cancer nanotechnology.
    Bromma K; Cicon L; Beckham W; Chithrani DB
    Sci Rep; 2020 Jul; 10(1):12096. PubMed ID: 32694592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment.
    Alhussan A; Bromma K; Bozdoğan EPD; Metcalfe A; Karasinska J; Beckham W; Alexander AS; Renouf DJ; Schaeffer DF; Chithrani DB
    Curr Oncol; 2021 May; 28(3):1962-1979. PubMed ID: 34073974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Gold Nanoparticle in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblast Cells.
    Alhussan A; Palmerley N; Smazynski J; Karasinska J; Renouf DJ; Schaeffer DF; Beckham W; Alexander AS; Chithrani DB
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway.
    Pradhan R; Paul S; Das B; Sinha S; Dash SR; Mandal M; Kundu CN
    J Nutr Biochem; 2023 Mar; 113():109257. PubMed ID: 36572069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy.
    Piwocka O; Piotrowski I; Suchorska WM; Kulcenty K
    Front Mol Biosci; 2024; 11():1343523. PubMed ID: 38455762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of Peptides for Enhanced Uptake of PEGylayed Gold Nanoparticles.
    Cruje C; Chithrani BD
    J Nanosci Nanotechnol; 2015 Mar; 15(3):2125-31. PubMed ID: 26413630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion.
    Stylianou A; Gkretsi V; Stylianopoulos T
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1537-1546. PubMed ID: 29477748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
    Peng Z; Ye M; Ding H; Feng Z; Hu K
    J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.
    Bannister AH; Bromma K; Sung W; Monica M; Cicon L; Howard P; Chow RL; Schuemann J; Chithrani DB
    Br J Radiol; 2020 Feb; 93(1106):20190742. PubMed ID: 31778316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-responsive Sulfated Hyaluronic Acid Nanoparticles Targeting Tumor Cells and CAFs for the Treatment of Breast Cancer.
    Wang D; Wu J; Qi C; Dong J; Ding X; Yu G; Liu S; Zhang B; Gao Z; Wei X; Liu H
    Recent Pat Anticancer Drug Discov; 2022; 18(2):200-210. PubMed ID: 35538821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells.
    Zhang Y; Elechalawar CK; Hossen MN; Francek ER; Dey A; Wilhelm S; Bhattacharya R; Mukherjee P
    Bioact Mater; 2021 Feb; 6(2):326-332. PubMed ID: 32954051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
    Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
    World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
    Suzuki J; Tsuboi M; Ishii G
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.